Medpace
MEDP · NASDAQ
Bulios Fair Price
$496.58
17.2% downside
Current Price
$599.47
According to Bulios Fair Price, MEDP is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Medpace Holdings, Inc. (MEDP) is a global company specializing in clinical research and the development of drugs and medical devices. With over twenty years of experience in the field, Medpace provides comprehensive clinical trial services for pharmaceutical and biotechnology companies. The company is known for its expertise, technological innovation, and commitment to ensuring high-quality and safe pharmaceutical products. Medpace Holdings, Inc. (MEDP) shares could be suitable for investors looking to invest in a company playing a key role in clinical research and the development of drugs and medical devices.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
August James Troendle
Employees
6,500
Headquarters
Cincinnati
Upcoming events
Earnings
Upcoming earnings report